Overview of FDA Expedited Development and Approval Programs for Serious Conditions
Impact Pharmaceutical Services
MAY 4, 2022
Abbreviations: BLA= Biologics License Application; IND= Investigational New Drug; NDA= New Drug Application; RMAT= Regenerative Medicine Advanced Therapy. *A Abbreviations: BLA= Biologics License Application; NDA= New Drug Application. *A Overview of FDA’s Expedited Development Programs. Overview of FDA’s Expedited Approval Programs.
52 
Let's personalize your content